Regulators of apoptosis as anticancer targets

被引：10

作者：

Tolcher, AW

机构：

[1] Univ Texas, Hlth Sci Ctr, Dept Med, San Antonio, TX 78229 USA

[2] Canc Therapy & Res Ctr S Texas, Inst Drug Dev, San Antonio, TX 78229 USA

来源：

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2002年 / 16卷 / 05期

关键词：

D O I：

10.1016/S0889-8588(02)00046-1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Several therapeutic strategies for drug development focus on the enhancement of tumor cell apoptosis secondary to chemotherapy, irradiation, and hormone-therapy, and improved therapeutic gain for patients. Rationally derived molecularly-targeted agents directed to the regulation of bcl-2 family members (intrinsic pathway) are in late clinical studies, whereas several strategies that target the tumor necrosis factor receptor family (extrinsic pathway of apoptosis) are in late preclinical development. These therapeutic agents and the pathways that are targeted. are reviewed.

引用

页码：1255 / +

页数：15

共 95 条

[1]

AGHAJANIAN C, 2001, P AN M AM SOC CLIN, V20, P85

[2] Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL [J].

Altucci, L ;

Rossin, A ;

Raffelsberger, W ;

Reitmair, A ;

Chomienne, C ;

Gronemeyer, H .

NATURE MEDICINE, 2001, 7 (06) :680-686

[3] Safety and antitumor activity of recombinant soluble Apo2 ligand [J].

Ashkenazi, A ;

Pai, RC ;

Fong, S ;

Leung, S ;

Lawrence, DA ;

Masters, SA ;

Blackie, C ;

Chang, L ;

McMurtrey, AE ;

Hebert, A ;

DeForge, L ;

Koumenis, IL ;

Lewis, D ;

Harris, L ;

Bussiere, J ;

Koeppen, H ;

Shahrokh, Z ;

Schwall, RH .

JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (02) :155-162

[4] p53 upregulates cFLIP, inhibits transcription of NF-κB-regulated genes and induces caspase-8-independent cell death in DLD-1 cells [J].

Bartke, T ;

Siegmund, D ;

Peters, N ;

Reichwein, M ;

Henkler, F ;

Scheurich, P ;

Wajant, H .

ONCOGENE, 2001, 20 (05) :571-580

[5] Elevated levels of apoptosis regulator proteins p53 and bcl-2 are independent prognostic biomarkers in surgically treated clinically localized prostate cancer [J].

Bauer, JJ ;

Sesterhenn, IA ;

Mostofi, FK ;

McLeod, DG ;

Srivastava, S ;

Moul, JW .

JOURNAL OF UROLOGY, 1996, 156 (04) :1511-1516

[6]

CHEN HX, 2000, P AN M AM SOC CLIN, V19, pA178

[7]

Chi KN, 2001, CLIN CANCER RES, V7, P3920

[8] Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy [J].

Chinnaiyan, AM ;

Prasad, U ;

Shankar, S ;

Hamstra, DA ;

Shanaiah, M ;

Chenevert, TL ;

Ross, BD ;

Rehemtulla, A .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (04) :1754-1759

[9]

Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4961

[10] Isotype-dependent inhibition of tumor growth in vivo by monoclonal antibodies to death receptor 4 [J].

Chuntharapai, A ;

Dodge, K ;

Grimmer, K ;

Schroeder, K ;

Marsters, SA ;

Koeppen, H ;

Ashkenazi, A ;

Kim, KJ .

JOURNAL OF IMMUNOLOGY, 2001, 166 (08) :4891-4898

← 1 2 3 4 5 6 7 8 9 10 →